DE1374910U - - Google Patents

Info

Publication number
DE1374910U
DE1374910U DENDAT1374910D DE1374910DU DE1374910U DE 1374910 U DE1374910 U DE 1374910U DE NDAT1374910 D DENDAT1374910 D DE NDAT1374910D DE 1374910D U DE1374910D U DE 1374910DU DE 1374910 U DE1374910 U DE 1374910U
Authority
DE
Germany
Prior art keywords
dur
dlu
uin
dor
major
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1374910D
Other languages
German (de)
English (en)
Publication of DE1374910U publication Critical patent/DE1374910U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
DENDAT1374910D Active DE1374910U (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
DE1374910U true DE1374910U (cg-RX-API-DMAC7.html)

Family

ID=687744

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1374910D Active DE1374910U (cg-RX-API-DMAC7.html)

Country Status (1)

Country Link
DE (1) DE1374910U (cg-RX-API-DMAC7.html)

Similar Documents

Publication Publication Date Title
US20230000813A1 (en) Compound for the treatment of bovine or swine respiratory disease
BE1002406A5 (fr) Compositions pharmaceutiques.
DE69317494D1 (de) Zusammensetzungen, die mono oder polyhydroxylierte Aminosäuren zur Behandlung des Insulinunabhängigen Diabetes Mellitus enthalten
KR101462060B1 (ko) 치환된 4-페닐테트라하이드로이소퀴놀린, 이의 제조방법,약제로서의 이의 용도 및 이를 함유하는 약제
AR004961A1 (es) Modificacion cristalina v del clorhidrato de(r)-(-)-2-{n-[4-(1,1-dioxido-3- oxo-2,3-dihidro-benzisotiazol-2-il)-butil]-aminometil)cromano, unprocedimiento para su preparacion, medicamentos que lo contienen, el uso de dicho clorhidrato para la preparacion de medicamentos, una composicion para el
DE1374910U (cg-RX-API-DMAC7.html)
ATE336254T1 (de) Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
Melcher et al. Infection after intramedullary nailing: an experimental investigation on rabbits
DE69015885T2 (de) Enzyminhibitoren.
DK582588A (da) Infektionsforhindrende forbindelser og fremgangsmaade til deres anvendelse
MA27277A1 (fr) Le pentafluorosulfanyl-benzoylguanidine, methode pour sa production et son utilisation comme medicament ou agent de diagnostique et medicament le contenant
Hammond et al. The occurrence of a second asexual generation in the life cycle of Eimeria bovis in calves
EP0314011A3 (de) Purinderivate
ATE407710T1 (de) Implantat für den transport und die freigabe von pharmakologisch aktiven substanzen
US6352726B1 (en) Method of killing protozoa
DE69522702D1 (de) Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
Roshdy et al. The functional morphology of Haemaphysalis spiracles (Ixodoidea: Ixodidae)
US3943246A (en) Organic compounds
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
Hirsch et al. Subarachnoid hemorrhage following ephedrine and MAO inhibitor
Guarro Comments on recent human infections caused by ascomycetes
WO2000006535A1 (en) Tyrosine-derived compounds as calcium channel antagonists
US3320252A (en) Certain cycloalkyl benzylamines
Seabury et al. Mycetoma mandibularis due to Nocardia pelletieri
RU2234939C1 (ru) Лекарственный препарат сублингвальных таблеток, содержащий интерферон-альфа, и способ его получения